Group A Streptococcus Nucleic Acid Amplification Assay System
OYZ is the FDA product code for Group A Streptococcus Nucleic Acid Amplification Assay System, a class I device type, regulated under 21 CFR 866.3740. FDA's definition for this code reads: "An in vitro diagnostic test for the detection of Streptococcuc pyogenes (Group A beta hemolytic Streptococcus) in throat swab specimens from symptomatic patients". As of , FDA records hold one 510(k) clearance under this code, the most recent dated , and no recalls.
Classification record
- Product code
- OYZ
- Device name
- Group A Streptococcus Nucleic Acid Amplification Assay System
- FDA definition
- An in vitro diagnostic test for the detection of Streptococcuc pyogenes (Group A beta hemolytic Streptococcus) in throat swab specimens from symptomatic patients.
- Regulation
- 21 CFR 866.3740
- Device class
- Class I
- Review panel
- Microbiology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 1
- Ingested recalls
- 0
Clearances, product code OYZ
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2012 | 1 |
Applicants with the most clearances
Product code OYZ| Applicant | Clearances |
|---|---|
| Meridian Bioscience Inc | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
